Anaplastic Large Cell Lymphoma, ALK-Positive

Explore clinical trials studying Anaplastic Large Cell Lymphoma, ALK-Positive. Study availability and eligibility vary by location and protocol.

13 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Anaplastic Large Cell Lymphoma, ALK-Positive trial results

Completed

NCT02561273

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Stanford Cancer Institute Palo Alto, California, United States

University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Completed

NCT03603847

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: CHU Amiens - Hôpital Sud Amiens, France

CHU d'Estaing Clermont-Ferrand, France

APHP - Hopital Henri Mondor Créteil, France

CHU Grenoble Grenoble, France

View all 15 locations

Completed

NCT02419287

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: ASST-Monza Monza, Italy/MB, Italy